cjc1295 ipamorelin human trial cjc1925 — Pure Health CJC 1295 no DAC &

In research, higher circulating IGF-1 has been associated with an increased risk of certain cancers (such as prostate, breast, and colorectal)

There are currently almost 500 peptides recognized by the FDA as having therapeutic value to potentially treat various diseases, including [3]: Bone disorders Genetic disorders Cancer Infectious disease Cardiovascular problems Immune system Respiratory disorders Eye disorders Neurodegenerative problems Poor hormonal health Bone disorders Some of the most commonly used GHRH-promoting peptide drug products include tesamorelin, ipamorelin and sermorelin

This mimics normal physiology and avoids disrupting hormone feedback loops

Step 4: Ongoing Optimization Protocol A personalized recovery and wellness plan that evolves with you, supporting long-term results, performance, and longevity